| Literature DB >> 32561134 |
Anna Carolina Carvalho da Fonseca1, Diana Matias2, Luiz Henrique Medeiros Geraldo3, Felipe Saceanu Leser4, Iohana Pagnoncelli4, Celina Garcia4, Rackele Ferreira do Amaral4, Barbara Gomes da Rosa4, Izabella Grimaldi4, Eduardo Sabino de Camargo Magalhães5, Valentín Cóppola-Segovia6, Evellyn Mayla de Azevedo6, Silvio Marques Zanata6, Flavia Regina Souza Lima7.
Abstract
Stress inducible protein 1 (STI1) is a co-chaperone acting with Hsp70 and Hsp90 for the correct client proteins' folding and therefore for the maintenance of cellular homeostasis. Besides being expressed in the cytosol, STI1 can also be found both in the cell membrane and the extracellular medium playing several relevant roles in the central nervous system (CNS) and tumor microenvironment. During CNS development, in association with cellular prion protein (PrPc), STI1 regulates crucial events such as neuroprotection, neuritogenesis, astrocyte differentiation and survival. In cancer, STI1 is involved with tumor growth and invasion, is undoubtedly a pro-tumor factor, being considered as a biomarker and possibly therapeutic target for several malignancies. In this review, we discuss current knowledge and new findings on STI1 function as well as its role in tissue homeostasis, CNS and tumor progression.Entities:
Keywords: Cancer; Co-chaperone; Glia; Neuron; STI1; STIP1
Year: 2020 PMID: 32561134 DOI: 10.1016/j.cytogfr.2020.06.003
Source DB: PubMed Journal: Cytokine Growth Factor Rev ISSN: 1359-6101 Impact factor: 7.638